Related references
Note: Only part of the references are listed.Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era
Patricia Perez-Galan et al.
BLOOD (2011)
Central nervous system prophylaxis in mantle cell lymphoma
Moshe E. Gatt et al.
BLOOD (2009)
Mantle cell lymphoma with central nervous system involvement: frequency and clinical features
Saar Gill et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options
Andres J. M. Ferreri et al.
HEMATOLOGICAL ONCOLOGY (2009)
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
Eva Hoster et al.
BLOOD (2008)
Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment
Koen Van Besien et al.
LEUKEMIA & LYMPHOMA (2008)
What is the real risk of central nervous system involvement in mantle cell lymphoma?
Saar Gill et al.
LEUKEMIA & LYMPHOMA (2008)
Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report
Nancy D. Doolittle et al.
BLOOD (2008)
Central nervous system involvement in mantle cell lymphoma
A. Ferrer et al.
ANNALS OF ONCOLOGY (2008)
Update on the molecular biology of mantle cell lymphoma
F Bertoni et al.
HEMATOLOGICAL ONCOLOGY (2006)
Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab
P Feugier et al.
ANNALS OF ONCOLOGY (2004)
The leukemic presentation of mantle-cell lymphoma: Disease features and prognostic factors in 58 patients
E Matutes et al.
LEUKEMIA & LYMPHOMA (2004)
Share Paper
